PT3845230T - Composição farmacêutica para administração oral - Google Patents
Composição farmacêutica para administração oralInfo
- Publication number
- PT3845230T PT3845230T PT198551236T PT19855123T PT3845230T PT 3845230 T PT3845230 T PT 3845230T PT 198551236 T PT198551236 T PT 198551236T PT 19855123 T PT19855123 T PT 19855123T PT 3845230 T PT3845230 T PT 3845230T
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical composition
- oral administration
- oral
- administration
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018163234 | 2018-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3845230T true PT3845230T (pt) | 2023-09-27 |
Family
ID=69642788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT198551236T PT3845230T (pt) | 2018-08-31 | 2019-08-30 | Composição farmacêutica para administração oral |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210346392A1 (pt) |
| EP (1) | EP3845230B1 (pt) |
| JP (1) | JP7355020B2 (pt) |
| KR (1) | KR20210052495A (pt) |
| CN (1) | CN112638390A (pt) |
| CA (1) | CA3108993C (pt) |
| ES (1) | ES2958158T3 (pt) |
| MX (1) | MX2021002385A (pt) |
| PH (1) | PH12021550251A1 (pt) |
| PL (1) | PL3845230T3 (pt) |
| PT (1) | PT3845230T (pt) |
| SG (1) | SG11202101547WA (pt) |
| TW (1) | TW202023565A (pt) |
| WO (1) | WO2020045607A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022123701A1 (ja) | 2020-12-09 | 2022-06-16 | 昭和電工マテリアルズ株式会社 | 容器入り負極材、負極材の輸送方法、負極材保管容器及び負極材の保管方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58134033A (ja) | 1982-02-02 | 1983-08-10 | Fujisawa Pharmaceut Co Ltd | 医薬組成物 |
| MX2008013584A (es) * | 2006-04-26 | 2009-03-23 | Genentech Inc | Compuestos farmaceuticos. |
| BR112016007588A2 (pt) | 2013-10-17 | 2017-09-12 | Bayer Pharma AG | formas de dosagem farmacêutica compreendendo sódio 1-[6- (morfolina-4-il) pirimidina-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato |
| TWI648281B (zh) | 2013-10-17 | 2019-01-21 | 日商安斯泰來製藥股份有限公司 | 含硫二環式化合物 |
-
2019
- 2019-08-30 TW TW108131175A patent/TW202023565A/zh unknown
- 2019-08-30 CN CN201980055874.8A patent/CN112638390A/zh active Pending
- 2019-08-30 EP EP19855123.6A patent/EP3845230B1/en active Active
- 2019-08-30 US US17/272,028 patent/US20210346392A1/en active Pending
- 2019-08-30 CA CA3108993A patent/CA3108993C/en active Active
- 2019-08-30 JP JP2020539609A patent/JP7355020B2/ja active Active
- 2019-08-30 SG SG11202101547WA patent/SG11202101547WA/en unknown
- 2019-08-30 KR KR1020217009054A patent/KR20210052495A/ko active Search and Examination
- 2019-08-30 WO PCT/JP2019/034051 patent/WO2020045607A1/ja active Application Filing
- 2019-08-30 ES ES19855123T patent/ES2958158T3/es active Active
- 2019-08-30 MX MX2021002385A patent/MX2021002385A/es unknown
- 2019-08-30 PL PL19855123.6T patent/PL3845230T3/pl unknown
- 2019-08-30 PT PT198551236T patent/PT3845230T/pt unknown
-
2021
- 2021-02-02 PH PH12021550251A patent/PH12021550251A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3845230T3 (pl) | 2023-12-27 |
| JPWO2020045607A1 (ja) | 2021-08-12 |
| CA3108993A1 (en) | 2020-03-05 |
| JP7355020B2 (ja) | 2023-10-03 |
| US20210346392A1 (en) | 2021-11-11 |
| EP3845230A1 (en) | 2021-07-07 |
| EP3845230B1 (en) | 2023-07-12 |
| EP3845230A4 (en) | 2022-06-01 |
| ES2958158T3 (es) | 2024-02-02 |
| WO2020045607A1 (ja) | 2020-03-05 |
| PH12021550251A1 (en) | 2021-10-11 |
| CA3108993C (en) | 2023-10-17 |
| TW202023565A (zh) | 2020-07-01 |
| CN112638390A (zh) | 2021-04-09 |
| SG11202101547WA (en) | 2021-03-30 |
| KR20210052495A (ko) | 2021-05-10 |
| MX2021002385A (es) | 2021-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258464A (en) | Pharmaceutical compositions for oral administration of peptide drugs | |
| IL270812A (en) | Solid compositions for oral drug administration | |
| HUP1700253A1 (hu) | Szilárd orális gyógyszerkészítmények | |
| HK1248544A1 (zh) | 穩定的口服給藥用藥物組合物 | |
| EP3784214A4 (en) | LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | |
| IL282163A (en) | A pharmaceutical preparation for oral administration containing an aminopyrimidine derivative or its salt | |
| IL290469A (en) | Oral pharmaceutical preparation | |
| HK1245646A1 (zh) | 口服給藥用醫藥組合物 | |
| GB2591396B (en) | Pharmaceutical suspension for oral dosage | |
| SG11202101547WA (en) | Pharmaceutical composition for oral administration | |
| IL282842A (en) | Medicinal compounds for subcutaneous control | |
| HUE062682T2 (hu) | Ibuprofén tartalmú orális gyógyszerészeti készítmény | |
| FI3908321T3 (fi) | Farmaseuttinen koostumus | |
| PT3650024T (pt) | Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência | |
| HK1232144A1 (zh) | 經口給藥用醫藥組合物 | |
| GB2561723B (en) | A composition for oral administration | |
| EP4066852A4 (en) | PHARMACEUTICAL COMPOSITION |